Cargando…

International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework

BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited disease characterized by ventricular arrhythmias and progressive ventricular dysfunction. Genetic testing is recommended, and a pathogenic variant in an ARVC-associated gene is a major criterion for diagnosis accordin...

Descripción completa

Detalles Bibliográficos
Autores principales: James, Cynthia A., Jongbloed, Jan D.H., Hershberger, Ray E., Morales, Ana, Judge, Daniel P., Syrris, Petros, Pilichou, Kalliopi, Domingo, Argelia Medeiros, Murray, Brittney, Cadrin-Tourigny, Julia, Lekanne Deprez, Ronald, Celeghin, Rudy, Protonotarios, Alexandros, Asatryan, Babken, Brown, Emily, Jordan, Elizabeth, McGlaughon, Jennifer, Thaxton, Courtney, Kurtz, C. Lisa, van Tintelen, J. Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205996/
https://www.ncbi.nlm.nih.gov/pubmed/33831308
http://dx.doi.org/10.1161/CIRCGEN.120.003273
_version_ 1783708562409652224
author James, Cynthia A.
Jongbloed, Jan D.H.
Hershberger, Ray E.
Morales, Ana
Judge, Daniel P.
Syrris, Petros
Pilichou, Kalliopi
Domingo, Argelia Medeiros
Murray, Brittney
Cadrin-Tourigny, Julia
Lekanne Deprez, Ronald
Celeghin, Rudy
Protonotarios, Alexandros
Asatryan, Babken
Brown, Emily
Jordan, Elizabeth
McGlaughon, Jennifer
Thaxton, Courtney
Kurtz, C. Lisa
van Tintelen, J. Peter
author_facet James, Cynthia A.
Jongbloed, Jan D.H.
Hershberger, Ray E.
Morales, Ana
Judge, Daniel P.
Syrris, Petros
Pilichou, Kalliopi
Domingo, Argelia Medeiros
Murray, Brittney
Cadrin-Tourigny, Julia
Lekanne Deprez, Ronald
Celeghin, Rudy
Protonotarios, Alexandros
Asatryan, Babken
Brown, Emily
Jordan, Elizabeth
McGlaughon, Jennifer
Thaxton, Courtney
Kurtz, C. Lisa
van Tintelen, J. Peter
author_sort James, Cynthia A.
collection PubMed
description BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited disease characterized by ventricular arrhythmias and progressive ventricular dysfunction. Genetic testing is recommended, and a pathogenic variant in an ARVC-associated gene is a major criterion for diagnosis according to the 2010 Task Force Criteria. As incorrect attribution of a gene to ARVC can contribute to misdiagnosis, we assembled an international multidisciplinary ARVC Clinical Genome Resource Gene Curation Expert Panel to reappraise all reported ARVC genes. METHODS: Following a comprehensive literature search, six 2-member teams conducted blinded independent curation of reported ARVC genes using the semiquantitative Clinical Genome Resource framework. RESULTS: Of 26 reported ARVC genes, only 6 (PKP2, DSP, DSG2, DSC2, JUP, and TMEM43) had strong evidence and were classified as definitive for ARVC causation. There was moderate evidence for 2 genes, DES and PLN. The remaining 18 genes had limited or no evidence. RYR2 was refuted as an ARVC gene since clinical data and model systems exhibited a catecholaminergic polymorphic ventricular tachycardia phenotype. In ClinVar, only 5 pathogenic/likely pathogenic variants (1.1%) in limited evidence genes had been reported in ARVC cases in contrast to 450 desmosome gene variants (97.4%). CONCLUSIONS: Using the Clinical Genome Resource approach to gene-disease curation, only 8 genes (PKP2, DSP, DSG2, DSC2, JUP, TMEM43, PLN, and DES) had definitive or moderate evidence for ARVC, and these genes accounted for nearly all pathogenic/likely pathogenic ARVC variants in ClinVar. Therefore, only pathogenic/likely pathogenic variants in these 8 genes should yield a major criterion for ARVC diagnosis. Pathogenic/likely pathogenic variants identified in other genes in a patient should prompt further phenotyping as variants in many of these genes are associated with other cardiovascular conditions.
format Online
Article
Text
id pubmed-8205996
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-82059962021-06-16 International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework James, Cynthia A. Jongbloed, Jan D.H. Hershberger, Ray E. Morales, Ana Judge, Daniel P. Syrris, Petros Pilichou, Kalliopi Domingo, Argelia Medeiros Murray, Brittney Cadrin-Tourigny, Julia Lekanne Deprez, Ronald Celeghin, Rudy Protonotarios, Alexandros Asatryan, Babken Brown, Emily Jordan, Elizabeth McGlaughon, Jennifer Thaxton, Courtney Kurtz, C. Lisa van Tintelen, J. Peter Circ Genom Precis Med Original Articles BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited disease characterized by ventricular arrhythmias and progressive ventricular dysfunction. Genetic testing is recommended, and a pathogenic variant in an ARVC-associated gene is a major criterion for diagnosis according to the 2010 Task Force Criteria. As incorrect attribution of a gene to ARVC can contribute to misdiagnosis, we assembled an international multidisciplinary ARVC Clinical Genome Resource Gene Curation Expert Panel to reappraise all reported ARVC genes. METHODS: Following a comprehensive literature search, six 2-member teams conducted blinded independent curation of reported ARVC genes using the semiquantitative Clinical Genome Resource framework. RESULTS: Of 26 reported ARVC genes, only 6 (PKP2, DSP, DSG2, DSC2, JUP, and TMEM43) had strong evidence and were classified as definitive for ARVC causation. There was moderate evidence for 2 genes, DES and PLN. The remaining 18 genes had limited or no evidence. RYR2 was refuted as an ARVC gene since clinical data and model systems exhibited a catecholaminergic polymorphic ventricular tachycardia phenotype. In ClinVar, only 5 pathogenic/likely pathogenic variants (1.1%) in limited evidence genes had been reported in ARVC cases in contrast to 450 desmosome gene variants (97.4%). CONCLUSIONS: Using the Clinical Genome Resource approach to gene-disease curation, only 8 genes (PKP2, DSP, DSG2, DSC2, JUP, TMEM43, PLN, and DES) had definitive or moderate evidence for ARVC, and these genes accounted for nearly all pathogenic/likely pathogenic ARVC variants in ClinVar. Therefore, only pathogenic/likely pathogenic variants in these 8 genes should yield a major criterion for ARVC diagnosis. Pathogenic/likely pathogenic variants identified in other genes in a patient should prompt further phenotyping as variants in many of these genes are associated with other cardiovascular conditions. Lippincott Williams & Wilkins 2021-04-08 /pmc/articles/PMC8205996/ /pubmed/33831308 http://dx.doi.org/10.1161/CIRCGEN.120.003273 Text en © 2021 The Authors. https://creativecommons.org/licenses/by/4.0/Circulation: Genomic and Precision Medicine is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
spellingShingle Original Articles
James, Cynthia A.
Jongbloed, Jan D.H.
Hershberger, Ray E.
Morales, Ana
Judge, Daniel P.
Syrris, Petros
Pilichou, Kalliopi
Domingo, Argelia Medeiros
Murray, Brittney
Cadrin-Tourigny, Julia
Lekanne Deprez, Ronald
Celeghin, Rudy
Protonotarios, Alexandros
Asatryan, Babken
Brown, Emily
Jordan, Elizabeth
McGlaughon, Jennifer
Thaxton, Courtney
Kurtz, C. Lisa
van Tintelen, J. Peter
International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework
title International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework
title_full International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework
title_fullStr International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework
title_full_unstemmed International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework
title_short International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework
title_sort international evidence based reappraisal of genes associated with arrhythmogenic right ventricular cardiomyopathy using the clinical genome resource framework
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205996/
https://www.ncbi.nlm.nih.gov/pubmed/33831308
http://dx.doi.org/10.1161/CIRCGEN.120.003273
work_keys_str_mv AT jamescynthiaa internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework
AT jongbloedjandh internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework
AT hershbergerraye internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework
AT moralesana internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework
AT judgedanielp internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework
AT syrrispetros internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework
AT pilichoukalliopi internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework
AT domingoargeliamedeiros internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework
AT murraybrittney internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework
AT cadrintourignyjulia internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework
AT lekannedeprezronald internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework
AT celeghinrudy internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework
AT protonotariosalexandros internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework
AT asatryanbabken internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework
AT brownemily internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework
AT jordanelizabeth internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework
AT mcglaughonjennifer internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework
AT thaxtoncourtney internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework
AT kurtzclisa internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework
AT vantintelenjpeter internationalevidencebasedreappraisalofgenesassociatedwitharrhythmogenicrightventricularcardiomyopathyusingtheclinicalgenomeresourceframework